Timothy Fuller has joined Banner Health in Northern Colorado to bring expertise and access to specialized care for patients with conditions affecting blood vessels and blood flow.
This capital injection will expedite the development and commercialisation of Okami's catheter-based technologies for ...
The skin condition eczema appears to be linked to a serious condition that can end in leg amputation, a new study fin ...
People living with atopic dermatitis (AD, also known as eczema) are also at significantly higher risk for peripheral vascular ...
The connection between gum disease and thrombosis underscores the role of oral health in reducing thrombotic disease risk and ...
Isomab Ltd. has nominated ISM-001 as a development candidate for peripheral arterial disease. ISM-001 is a potential first-in-class therapeutic antibody designed to neutralize VEGF-A165b, the ...
This scientific statement emphasizes the complexity of managing aortopathy in children, noting that management differs ...
Amplitude Vascular Systems (AVS), which is focused on treating severely calcified arterial disease, announced commencement of ...
Amplitude Vascular Systems enrolled the first patient(s) in the U.S. pivotal trial for its intravascular lithotripsy (IVL) ...
Historical discrimination, lack of qualified interpreters, and inadequate access to care contribute to worse outcomes among ...